Company: IPGP
Filing Date: 2025-04-07
Form Type: DEF 14A
Source: 0001111928-25-000054
Chunk: 85

Company: IPG PHOTONICS CORP
Filing Date: 2025-04-07
Form: DEF 14A
Chunk 85
---
438 |                    |    |         — |     |                 | 2,093,139 |    |               |   178,305 |    |               |  65 |    |     | 125 |    |        |  111 |    |       | 1,430 |    |
| 2021 |     |            |                            |         — |     |           | 7,284,851 |     |    | 3,254,034 |     |            |                                |         — |     |    | 1,633,757 |                    |    | 3,254,034 |     |                 | 2,641,365 |    |               |   414,607 |    |               | 119 |    |     | 160 |    |        |  278 |    |       | 1,461 |    |
| 2020 |     |            |                            |         — |     |           |         — |     |    | 1,943,900 |     |            |                                |         — |     |    |         — |                    |    | 1,943,900 |     |                 | 2,538,192 |    |               | 4,578,077 |    |               | 154 |    |     | 124 |    |        |  160 |    |       | 1,201 |    |

Columns (b) . Reflects compensation amounts reported in the “Total” column of the “Summary Compensation Table” for Dr. Mark Gitin, Dr. Eugene Scherbakovand Dr. Valentin Gapontsev, for the respective years shown. Dr. Gapontsev was CEO until May 4, 2021, when Dr. Scherbakov succeeded him. Dr. Scherbakov was CEO from May 4, 2021 to June 5, 2024, when Dr. Gitin succeeded him.

Columns (c). The dollar amounts reported for Dr. Gitin, Dr. Scherbakov and Dr. Gapontsev under “Compensation Actually Paid” represent the amount of “compensation actually paid” to Dr. Gitin, Dr. Scherbakov and Dr. Gapontsev, as computed in accordance with Item 402(v) of Regulation S-K. The dollar amounts do not reflect the actual amount of compensation earned by or paid to Dr. Gitin or Dr. Scherbakov